Get your replacement heart tissue and blood vessels now

Cell therapy holds huge potential for the future of treatment of a wide range of disorders and conditions, but what is less obvious is the extent to which cell therapy, and tissue engineering in general, is already in current clinical practice, and how close a wave of new products is to gaining regulatory approval and entering the market.  As we have previously noted, the global cell therapy and tissue engineering market is already a $6.9 billion market. 

Over three dozen companies are working on cardiovascular applications of tissue engineering and cell therapies.  Almost half of these companies have a product in clinical trials and at least ten companies have approved products.

  • 3DM Inc.
  • Aastrom Bioscience Inc.
  • Advanced Cell Technology, Inc.
  • AdvanSource Biomaterials
  • Aldagen, Inc.
  • Angioblast Systems, Inc.
  • Angiotech Pharmaceuticals, Inc.
  • Arteriocyte Medical Systems, Inc.
  • Athersys, Inc.
  • Baxter International Inc.
  • BeFutur Biotechnologies
  • Bio Nova International
  • Bioheart Inc.
  • California Stem Cell Inc.
  • Capstone Therapeutics
  • CellSeed, Inc.
  • Cook Group
  • CryoLife, Inc.
  • Cytograft Tissue Engineering
  • Cytori Therapeutics Inc.
  • ES Cell International
  • Garnet BioTherapeutics
  • Genzyme Corporation
  • Geron Corporation
  • Humacyte
  • Kensey Nash
  • Medtronic
  • Mesoblast Limited
  • MG Biotherapeutics, LLC
  • Miltenyi Biotec
  • NellOne Therapeutics, Inc.
  • Organovo
  • Osiris Therapeutics Inc.
  • Pluristem Therapeutics, Inc.
  • ReNeuron Ltd.
  • Stem Cell Therapy International, Inc. / Histostem
  • Targeted Genetics Corporation
  • Tepha Inc.
  • TriStem Corporation

Cardiovascular applications are currently among the fastest growing in cell therapy, based on the state of the science in these technologies, their rapid uptake for use by medical practitioners and the acute need for the treatment solutions they offer.

Source: "Tissue Engineering, Cell Therapy and Transplantation: Products, Technologies & Market Opportunities, Worldwide, 2009-2018," Report #S520. Published February 2010. © MedMarket Diligence, LLC.

Leave a Reply